Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bulgaria invests in cancer screening:

This article was originally published in Clinica

Executive Summary

Bulgaria is to allocate Lev1.7 million ($770,000) to a five-year cervical cancer screening programme. Some 650,000 women between the ages of 25 and 60 will be offered screening every three years. This is part of a cancer prevention programme aimed at reducing cervical, prostate and breast cancer. A further Lev10 million will be allocated to mammograms for annual checks of women aged 40-49 and every three years for women aged 50-69. Some 600,000 women will benefit. A total of Lev1.5 million will go towards annual prostate cancer examinations for men over 45.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075372

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel